Standards › ASF Health Standards v10 › Standard 33
Standard 33
Laboratory
Laboratory services: calibration, reagent and method validation, quality control, external assessment, specimen handling, turnaround, chain of custody, critical values, authorisation, reporting and supplier qualification..
Each criterion is shown in three settings: Humanitarian settings, Transition and fragile, and Standard. In standard settings, every criterion is Must.
Training colours: red means essential, green recommended, yellow optional. Each course shows its level for each setting: humanitarian, transition and fragile, and standard.
33.1Calibration Current and Traceable to a ReferenceHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Each instrument and measuring device is calibrated or verified at the set interval against a traceable reference, and its calibration status is current before any patient result is released.
Why it matters. An instrument that is out of calibration gives results that look normal and are wrong. Calibration kept current on every instrument that produces a reportable result is the basis of accurate results.
How the surveyor verifies this criterion
Sample. Review the calibration and maintenance records for all measuring devices for the last 12 months, and the traceability certificates.
1. Each device is calibrated or verified at the set interval.
Method. Check each device on the register against its calibration date and interval.
Evidence to show. Equipment calibration and traceability (LBT-POL-001).
Pass when. Every device is within its calibration interval.
2. Calibration is traceable to a reference standard.
Method. Check the certificate for each calibration for the traceable reference cited.
Evidence to show. Calibration and maintenance register (LBT-REG-001).
Pass when. Every calibration certificate names a traceable reference.
3. A device out of calibration is withdrawn from patient testing.
Method. Check each failed or overdue calibration for the withdrawal record.
Evidence to show. Calibration and maintenance register (LBT-REG-001).
Pass when. Every failed or overdue device has a withdrawal record.
Immediate fail (any one means the criterion is not met). A chemistry analyser used for patient results eight months after its calibration expired.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Equipment calibration and traceability | Must |
| Secretary (ISCO 3344) | Keeps the Calibration and maintenance register | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-REG-001 · Calibration and maintenance register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
| LBT-POL-001 · Equipment calibration and traceability | Chief executive (ISCO 1120) | Governing body members | N/A | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Equipment, calibration, maintenance and environment (L-05) | Manager; Nurse |
References
33.2Reagent Lots Verified Before UseHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Each new reagent lot is checked against the previous lot or the manufacturer’s acceptance criteria before it is used for patient testing, and the check is recorded.
Why it matters. A new batch of reagent can behave differently from the last. Checking each new lot against the laboratory’s own quality control before use prevents results going wrong unnoticed.
How the surveyor verifies this criterion
Sample. Review the reagent lot verification records for 20 new reagent lots in the last 12 months.
1. Each new lot is checked before it is used on patients.
Method. Check each lot receipt for the verification entry dated before first use.
Evidence to show. Reagent lot verification record (LBT-FRM-001).
Pass when. Every sampled lot has a verification dated before first use.
2. The check follows the manufacturer’s acceptance criteria.
Method. Check each verification for the criteria and the result recorded.
Evidence to show. Reagent lot verification record (LBT-FRM-001).
Pass when. Every verification records the criteria and the result.
3. A lot that fails is not used.
Method. Check each failed lot for its removal from use.
Evidence to show. Reagent lot verification record (LBT-FRM-001).
Pass when. No failed lot appears in patient testing.
Immediate fail (any one means the criterion is not met). A new reagent lot used on patients without any check against the previous lot.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Nurse (ISCO 2221) | Completes the Reagent lot verification record | Must |
| Manager (ISCO 1342) | Checks the criterion at each review | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-FRM-001 · Reagent lot verification record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Equipment, Reagents & Traceability (LAB-04) | Manager; Nurse |
References
33.3Method Validated Before Clinical UseHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Each test method is validated for its intended clinical use, covering precision, accuracy, reportable range and reference intervals, before it is used on patients.
Why it matters. A method used for patient results must first be shown to work for this laboratory. Validation or verification before clinical use prevents results from an unproven method.
How the surveyor verifies this criterion
Sample. Review the method validation records for the last 5 tests introduced or changed in the last 2 years.
1. Each method is validated for its intended use before patient testing.
Method. Check each validation report for its date against the first patient result.
Evidence to show. Method validation before clinical use (LBT-SOP-001).
Pass when. Every method was validated before its first patient result.
2. The validation covers precision, accuracy, reportable range and reference interval.
Method. Check each report for these four elements.
Evidence to show. Method validation register (LBT-REG-002).
Pass when. Every report covers all four elements.
3. A method change triggers revalidation.
Method. Check each change in the register for a revalidation entry.
Evidence to show. Method validation register (LBT-REG-002).
Pass when. Every change has a revalidation entry before use.
Immediate fail (any one means the criterion is not met). A new assay put into clinical use on the manufacturer’s claims alone, with no local validation.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Method validation before clinical use | Must |
| Secretary (ISCO 3344) | Keeps the Method validation register | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-SOP-001 · Method validation before clinical use | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| LBT-REG-002 · Method validation register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Equipment, Reagents & Traceability (LAB-04) | Manager; Nurse |
References
- WHO (2026). Guidance on evidence generation on new tuberculosis diagnostics. Used for: Evidence needed before new TB diagnostic tests are used: validation, performance and reporting. TB-specific. https://news.gmj.ge/guideline/guidance-on-evidence-generation-on-new-tuberculosis-diagnostics/
- WHO (2025). Operational handbook on tuberculosis. Module 3: Diagnosis. Used for: Operational handbook, Module 3 on TB diagnosis: specimen collection, laboratory testing, result reporting and interpretation. TB-specific, not a general laboratory standard. https://news.gmj.ge/guideline/operational-handbook-on-tuberculosis-module-3-diagnosis/
33.4Internal Quality Control Run Before Results Are ReleasedHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Internal quality control material is run at the set interval and with each analytical run, and results are reviewed against defined rules before patient results are released.
Why it matters. Quality control shows whether a test is working on the day. A result released before the control has been run and accepted may be wrong.
How the surveyor verifies this criterion
Sample. Review the internal quality control log for 30 analytical runs and the rules applied.
1. Quality control is run at the set interval and with each run.
Method. Check each run in the sample for the quality control entry.
Evidence to show. Internal quality control (LBT-SOP-002).
Pass when. Every sampled run has quality control recorded.
2. Control results are reviewed against defined rules before release.
Method. Check each run for the rule applied and the review recorded.
Evidence to show. Internal quality control log (LBT-REG-003).
Pass when. Every run records the rule review before release.
3. An out-of-control run is not released and is corrected.
Method. Check each out-of-control run for the hold and the corrective action.
Evidence to show. Internal quality control log (LBT-REG-003).
Pass when. Every out-of-control run is held and corrected before results are released.
Immediate fail (any one means the criterion is not met). Patient results released from a run where the control was outside its limit.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Internal quality control | Must |
| Secretary (ISCO 3344) | Keeps the Internal quality control log | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-SOP-002 · Internal quality control | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| LBT-REG-003 · Internal quality control log | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Equipment, calibration, maintenance and environment (L-05) | Manager; Nurse |
References
33.5External Quality Assessment ParticipationHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
The laboratory takes part in external quality assessment for each test it performs where a scheme exists, and acts on every unsatisfactory result.
Why it matters. A laboratory that does not compare its results with others may have a problem it cannot see. External quality assessment shows how its results compare with peers.
How the surveyor verifies this criterion
Sample. Review the external quality assessment participation and results for the last 24 months for each test performed.
1. The laboratory takes part in an external scheme for each test where one exists.
Method. Check the participation record against the list of tests performed.
Evidence to show. External quality assessment participation (LBT-POL-002).
Pass when. Every test with a scheme has participation recorded.
2. Each unsatisfactory result is investigated and acted on.
Method. Check each unsatisfactory result for the investigation and the corrective action.
Evidence to show. External quality assessment results register (LBT-REG-004).
Pass when. Every unsatisfactory result has an investigation and action.
3. Results are reviewed at a set interval by the laboratory lead.
Method. Check the review entries for the set interval.
Evidence to show. External quality assessment results register (LBT-REG-004).
Pass when. Every result is reviewed at the set interval.
Immediate fail (any one means the criterion is not met). Three unsatisfactory external results for one test with no investigation.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the External quality assessment participation | Must |
| Secretary (ISCO 3344) | Keeps the External quality assessment results register | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-REG-004 · External quality assessment results register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
| LBT-POL-002 · External quality assessment participation | Chief executive (ISCO 1120) | Governing body members | N/A | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Equipment, calibration, maintenance and environment (L-05) | Manager; Nurse |
References
33.6Test Indications, Limitations and Patient Preparation Given to UsersHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Clinicians and patients receive information on the indications, limitations and required preparation for each test, in the test catalogue or on the request form.
Why it matters. A clinician who orders a test without knowing what it can and cannot tell them will misread the result. Clear written information on each test’s purpose and limits is part of a safe result.
How the surveyor verifies this criterion
Sample. Review the test catalogue and request forms for 15 tests, and 10 request forms completed in the last 3 months.
1. Each test states its indication and limitations.
Method. Check each catalogue entry for the indication and limitation text.
Evidence to show. Test request information sheet (LBT-FRM-002).
Pass when. Every catalogue entry states indication and limitation.
2. Patient preparation is stated for each test that needs it.
Method. Check each entry that needs preparation for the instructions given.
Evidence to show. Test request information sheet (LBT-FRM-002).
Pass when. Every test that needs preparation states it.
3. Clinicians receive the information at the point of request.
Method. Check each completed request form for the information attached or referenced.
Evidence to show. Test information for users (LBT-SOP-010).
Pass when. Every request form carries or refers to the test information.
Immediate fail (any one means the criterion is not met). A fasting test requested with no instruction given to the patient.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Nurse (ISCO 2221) | Completes the Test request information sheet | Medium |
| Manager (ISCO 1342) | Maintains the Test information for users | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-SOP-010 · Test information for users | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| LBT-FRM-002 · Test request information sheet | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Pre-examination — patient preparation, collection, identification, transport, reception (L-04) | Manager; Nurse |
References
- WHO (2025). Operational handbook on tuberculosis. Module 3: Diagnosis. Used for: Operational handbook, Module 3 on TB diagnosis: specimen collection, laboratory testing, result reporting and interpretation. TB-specific, not a general laboratory standard. https://news.gmj.ge/guideline/operational-handbook-on-tuberculosis-module-3-diagnosis/
33.7Specimens Accepted, Logged and Rejected by Defined CriteriaHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Specimens are accepted, logged and rejected against defined acceptance criteria, and every rejection is recorded with its reason and the notice given to the requester.
Why it matters. A specimen that is haemolysed, clotted or too small can give a wrong result. Written rejection criteria, applied the same way by everyone, stop it being tested.
How the surveyor verifies this criterion
Sample. Review the specimen receipt and rejection log for 30 rejected specimens and 30 accepted specimens in the last 3 months.
1. Each specimen is checked against the acceptance criteria on receipt.
Method. Check each receipt entry for the criteria checked.
Evidence to show. Specimen acceptance and rejection (LBT-SOP-003).
Pass when. Every receipt records the criteria checked.
2. Each rejection records the reason and the notice given to the requester.
Method. Check each rejection for the reason and the notice date.
Evidence to show. Specimen receipt and rejection log (LBT-REG-005).
Pass when. Every rejection records reason and notice.
3. Accepted specimens are logged and identified.
Method. Check each accepted specimen for the log entry and identifiers.
Evidence to show. Specimen receipt and rejection log (LBT-REG-005).
Pass when. Every accepted specimen is logged with its identifiers.
Immediate fail (any one means the criterion is not met). A specimen with no patient identifier accepted and tested.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Specimen acceptance and rejection | Must |
| Secretary (ISCO 3344) | Keeps the Specimen receipt and rejection log | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-SOP-003 · Specimen acceptance and rejection | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| LBT-REG-005 · Specimen receipt and rejection log | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Equipment, Reagents & Traceability (LAB-04) | Manager; Nurse |
References
33.8Specimen Transport Preserves IntegrityHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Specimens are transported in conditions that preserve their integrity, including packaging, temperature, time limits and labelling, and every deviation is recorded.
Why it matters. Some specimens change in transit if they are too warm, too cold, or left too long. The transport conditions must keep the specimen as it was taken.
How the surveyor verifies this criterion
Sample. Observe specimen transport from collection to the laboratory for 10 deliveries and review the transport records.
1. Specimens are packed and labelled to preserve integrity.
Method. Observe the packaging and labelling of sampled deliveries.
Evidence to show. Specimen transport (LBT-SOP-004).
Pass when. Every sampled delivery is packed and labelled correctly.
2. Temperature and time limits are kept and recorded.
Method. Check each transport record for temperature and time against the limit.
Evidence to show. Specimen transport record (LBT-FRM-003).
Pass when. Every record is within its temperature and time limit.
3. Each deviation is recorded and the specimen is assessed.
Method. Check each deviation for the record and the decision on the specimen.
Evidence to show. Specimen transport record (LBT-FRM-003).
Pass when. Every deviation has a record and a decision.
Immediate fail (any one means the criterion is not met). A specimen left in a hot vehicle for three hours and tested without a deviation record.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Specimen transport | Must |
| Nurse (ISCO 2221) | Completes the Specimen transport record | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-SOP-004 · Specimen transport | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| LBT-FRM-003 · Specimen transport record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Equipment, calibration, maintenance and environment (L-05) | Manager; Nurse |
References
33.9STAT Specimens Prioritised and Turnaround MonitoredHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
STAT specimens are identified and prioritised, and turnaround time for STAT and routine tests is monitored against defined targets.
Why it matters. An urgent (STAT) specimen that waits in the queue can delay treatment for a critical patient. A written procedure to flag, handle and track urgent specimens gets them to the front.
How the surveyor verifies this criterion
Sample. Review the STAT specimen log and the turnaround time records for the last 3 months.
1. STAT specimens are identified and prioritised on receipt.
Method. Check each STAT specimen for its identification and its priority in the workflow.
Evidence to show. STAT specimens and turnaround (LBT-SOP-005).
Pass when. Every STAT specimen is identified and prioritised.
2. Turnaround is measured against the defined targets.
Method. Check the turnaround log for each target against the actual time.
Evidence to show. Turnaround time monitoring log (LBT-REG-006).
Pass when. Turnaround is measured for every test against its target.
3. Targets missed are reviewed and acted on.
Method. Check each missed target for the review and action.
Evidence to show. Turnaround time monitoring log (LBT-REG-006).
Pass when. Every missed target has a review and action.
Immediate fail (any one means the criterion is not met). A STAT potassium result left in the queue for four hours with no alert.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the STAT specimens and turnaround | Medium |
| Secretary (ISCO 3344) | Keeps the Turnaround time monitoring log | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-SOP-005 · STAT specimens and turnaround | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| LBT-REG-006 · Turnaround time monitoring log | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Equipment, Reagents & Traceability (LAB-04) | Manager; Nurse |
References
33.10Chain of Custody for Forensic or Legal SpecimensHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Forensic and legal specimens are handled under a documented chain of custody from collection to disposal, and every transfer is signed.
Why it matters. A specimen used as legal evidence must show, at each step, who held it and what happened to it. Without that custody record, the evidence can be challenged.
How the surveyor verifies this criterion
Sample. Review the chain of custody forms for 10 forensic or legal specimens in the last 12 months.
1. Each specimen has a chain of custody from collection.
Method. Check each form for the first entry at collection.
Evidence to show. Chain of custody for forensic and legal specimens (LBT-SOP-006).
Pass when. Every sampled specimen has a form from collection.
2. Each transfer is signed and dated.
Method. Check each transfer on the form for a signature and date.
Evidence to show. Chain of custody form (LBT-FRM-004).
Pass when. Every transfer is signed and dated.
3. The specimen is disposed of only as recorded.
Method. Check the disposal entry against the form.
Evidence to show. Chain of custody form (LBT-FRM-004).
Pass when. Every disposal matches the recorded custody.
Immediate fail (any one means the criterion is not met). A legal specimen with a gap in custody between two staff members.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Chain of custody | Medium |
| Nurse (ISCO 2221) | Completes the Chain of custody form | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-SOP-006 · Chain of custody for forensic and legal specimens | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| LBT-FRM-004 · Chain of custody form | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Records, Confidentiality and Data Protection (T-11) | Manager; Nurse |
References
In process of development. Will be available soon.
33.11Critical Values Communicated and Receipt VerifiedHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Critical values are communicated to a responsible clinician by a defined route within a defined time, and receipt is verified and recorded.
Why it matters. A critical result, such as a dangerously high potassium, must reach a responsible clinician at once. A result left in a report or on a screen can cost a life.
How the surveyor verifies this criterion
Sample. Review the critical value log for 30 critical results in the last 3 months.
1. Each critical value is communicated to a responsible clinician.
Method. Check each log entry for the recipient named.
Evidence to show. Critical value communication (LBT-SOP-007).
Pass when. Every critical value names a responsible recipient.
2. Communication happens within the defined time.
Method. Check each entry for the time from result to communication.
Evidence to show. Critical value communication log (LBT-REG-007).
Pass when. Every communication is within the defined time.
3. Receipt is verified and recorded.
Method. Check each entry for the read-back and receipt confirmation.
Evidence to show. Critical value communication log (LBT-REG-007).
Pass when. Every entry records receipt confirmed.
Immediate fail (any one means the criterion is not met). A critical potassium result left on a voicemail and not acted on.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Critical value communication | Must |
| Secretary (ISCO 3344) | Keeps the Critical value communication log | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-SOP-007 · Critical value communication | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| LBT-REG-007 · Critical value communication log | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Incident Reporting, Just Culture and Open Disclosure (T-09) | Manager; Nurse |
References
- World Health Organization (2021). Global Patient Safety Action Plan 2021–2030: Towards Eliminating Avoidable Harm in Health Care. Geneva: WHO. https://www.who.int/publications-detail-redirect/9789240032705 Used for: https://news.gmj.ge/guideline/global-patient-safety-action-plan-2021-2030-towards-eliminating-avoidable-harm-in-health-care/
33.12Results Authorised Before ReleaseHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Each result is authorised for release by a qualified person before it leaves the laboratory, and the person authorising is recorded.
Why it matters. A result released without being checked by qualified staff can carry an error to the clinician. A review and authorisation before release is the last check.
How the surveyor verifies this criterion
Sample. Review the authorisation records for 30 released results and the competence records of the authorising staff.
1. Each result is authorised before release by a qualified person.
Method. Check each result for the authoriser and the time before release.
Evidence to show. Result authorisation and release (LBT-POL-003).
Pass when. Every released result has an authoriser before release.
2. The authoriser is competent for the test.
Method. Check the authoriser against the competence register for the test.
Evidence to show. Result authorisation record (LBT-FRM-005).
Pass when. Every authoriser is competent for the test.
3. The authoriser is recorded with the result.
Method. Check each result record for the name recorded.
Evidence to show. Result authorisation record (LBT-FRM-005).
Pass when. Every released result shows the authoriser.
Immediate fail (any one means the criterion is not met). A result released by a trainee with no authorisation.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Result authorisation and release | Must |
| Nurse (ISCO 2221) | Completes the Result authorisation record | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-FRM-005 · Result authorisation record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
| LBT-POL-003 · Result authorisation and release | Chief executive (ISCO 1120) | Governing body members | N/A | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Credentialing, Competence and the Training Matrix (T-14) | Manager; Nurse |
References
33.13Reports Meet a Defined Minimum and Reach the Correct RecipientHumanitarian settings: MustTransition and fragile: MustStandard: Must
Each report contains a defined minimum set of information, including identifiers, test name, result, units, reference interval and authoriser, and reaches the correct recipient.
Why it matters. A report without the patient’s identity, the specimen type or the test date cannot be used safely. Every report must carry a defined minimum of information.
How the surveyor verifies this criterion
Sample. Review 20 laboratory reports and the delivery records for the last 3 months.
1. Each report contains the defined minimum information.
Method. Check each report against the minimum content list.
Evidence to show. Laboratory report content and delivery (LBT-SOP-008).
Pass when. Every report contains all the minimum content.
2. The report reaches the correct recipient.
Method. Check each delivery against the requester recorded.
Evidence to show. Laboratory report content and delivery (LBT-SOP-008).
Pass when. Every report reaches the requester named.
3. Reports carry the authoriser and reference interval.
Method. Check each report for the authoriser and the reference interval.
Evidence to show. Laboratory report content and delivery (LBT-SOP-008).
Pass when. Every report carries both.
Immediate fail (any one means the criterion is not met). A report sent to the wrong ward, with another patient’s result on it.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Laboratory report content and delivery | Must |
| Manager (ISCO 1342) | Checks the criterion at each review | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-SOP-008 · Laboratory report content and delivery | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Records, Confidentiality and Data Protection (T-11) | Manager; Nurse |
References
33.14Result Amendments Traceable to the OriginalHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Any change to a released result is recorded as an amendment, traceable to the original result, with the reason, the date and the person who made the change.
Why it matters. A result that is changed after release must show what it was and what it became, and why. Without that, the change cannot be trusted or reviewed.
How the surveyor verifies this criterion
Sample. Review the result amendment log for all amendments in the last 12 months.
1. Each amendment is recorded as an amendment to the original result.
Method. Check each amendment for the link to the original result.
Evidence to show. Result amendments (LBT-SOP-009).
Pass when. Every amendment is linked to the original.
2. Each amendment states its reason, date and person.
Method. Check each amendment entry for the reason, date and person.
Evidence to show. Result amendment log (LBT-REG-008).
Pass when. Every amendment states reason, date and person.
3. The original result remains visible in the record.
Method. Check the record for the original value kept.
Evidence to show. Result amendment log (LBT-REG-008).
Pass when. The original value is kept visible in every sampled case.
Immediate fail (any one means the criterion is not met). A released result overwritten with no record of the original value.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Result amendments | Medium |
| Secretary (ISCO 3344) | Keeps the Result amendment log | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-SOP-009 · Result amendments | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| LBT-REG-008 · Result amendment log | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Records, Confidentiality and Data Protection (T-11) | Manager; Nurse |
References
33.15Suppliers and Reagents QualifiedHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Suppliers of reagents, consumables and equipment services are qualified before use and reviewed at set intervals against defined requirements.
Why it matters. Reagents, consumables and outside services that are poor quality cause results to be wrong. Buying only from qualified suppliers, and monitoring them, keeps quality up.
How the surveyor verifies this criterion
Sample. Review the supplier qualification register and the purchase records for all reagent and service suppliers in use.
1. Each supplier is qualified before first use.
Method. Check each supplier on the register for the qualification date before the first purchase.
Evidence to show. Supplier and reagent qualification (LBT-POL-004).
Pass when. Every supplier was qualified before first use.
2. Qualification is reviewed at the set interval.
Method. Check each supplier for the review date against the interval.
Evidence to show. Supplier qualification register (LBT-REG-009).
Pass when. Every supplier is reviewed at the set interval.
3. Unqualified suppliers are not used.
Method. Check the purchase records against the register.
Evidence to show. Supplier qualification register (LBT-REG-009).
Pass when. No purchase is made from an unqualified supplier.
Immediate fail (any one means the criterion is not met). Reagents bought from an unlisted supplier with no quality documents on file.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Supplier and reagent qualification | Medium |
| Secretary (ISCO 3344) | Keeps the Supplier qualification register | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| LBT-REG-009 · Supplier qualification register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
| LBT-POL-004 · Supplier and reagent qualification | Chief executive (ISCO 1120) | Governing body members | N/A | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Supplier Evaluation and Purchasing (T-13) | Manager; Nurse |
References
Who is responsible for Standard 33
Each criterion names the positions responsible for it. Every position links to its own terms of reference.
Role details: reporting, supervision and training
Training shown is the general recommendation. Role-specific training is set in the next improvement round.
Questions and answers
The criterion text is the authority. These answers summarise it.
Who does Standard 28 apply to?
Laboratories that perform clinical tests on patient specimens, including specimen collection, transport, testing and reporting.
What do the colours mean for this standard?
Red (Must) is required. Green (Medium) is recommended. Yellow (Minimum) is the lowest acceptable level in humanitarian settings. Standard setting is Must on every criterion.
Can a new reagent lot be used on patients without a check?
No. Under 33.2 reagent lots are verified before use.
Can results be released without quality control?
No. Under 33.4 internal quality control is run before results are released.
Who authorises a result before it is released?
Under 33.12 results are authorised before release, so a trainee cannot release a result without authorisation.
What happens to a critical value?
Under 33.11 critical values are communicated and receipt is verified, not left on voicemail.
Do I have to use the documents on this page?
No. The policies, SOPs, forms and registers are drafts to help you. Adapt them to your laboratory, write your own, or upload your own. What the assessor checks is that the criterion is met and that you can show how.
What does In process of development mean?
That part of the standard is still being prepared. It may be a document, a course, a reference or a role table. It will be added in a later version.
Guidelines for this standard
55 guideline(s) are held in the GMJ Guidelines Library and listed here. Each link opens the full guideline on news.gmj.ge. The complete library, grouped by standard, is at Guidelines.
- Pulmonary tuberculosis — MSF Clinical guidelines (Médecins Sans Frontières)
- Medical laboratories – Requirements for quality and competence (ISO 15189:2022) (ISO)
- Treatment outcomes — MSF Tuberculosis (Médecins Sans Frontières)
- Case detection and enrolment — MSF Tuberculosis (Médecins Sans Frontières)
- Recording tools — MSF Tuberculosis (Médecins Sans Frontières)
- Patient monitoring during latent tuberculosis infection treatment — MSF Tuberculosis (Médecins Sans Frontières)
- Latent tuberculosis infection treatment regimens — MSF Tuberculosis (Médecins Sans Frontières)
- Treatment of latent tuberculosis infection — Introduction — MSF Tuberculosis (Médecins Sans Frontières)
- BCG vaccination for staff exposed to tuberculosis — MSF Tuberculosis (Médecins Sans Frontières)
- Preventive measures at patients’ homes — MSF Tuberculosis (Médecins Sans Frontières)
- Respiratory protection measures in health facilities — MSF Tuberculosis (Médecins Sans Frontières)
- Environmental Measures in Health Facilities — MSF Tuberculosis (Médecins Sans Frontières)
- Administrative measures in health facilities — MSF Tuberculosis (Médecins Sans Frontières)
- Tuberculosis infection prevention and control (Chapter 14.1: Introduction) — MSF Tuberculosis (Médecins Sans Frontières)
- Therapeutic patient education and patient support services — MSF Tuberculosis (Médecins Sans Frontières)
- Factors that influence adherence — MSF Tuberculosis (Médecins Sans Frontières)
- Treatment delivery model — MSF Tuberculosis (Médecins Sans Frontières)
- Immune Reconstitution Inflammatory Syndrome in TB-HIV Co-infection — MSF Tuberculosis (Médecins Sans Frontières)
- Concomitant treatment of tuberculosis and HIV co-infection — MSF Tuberculosis (Médecins Sans Frontières)
- Standard treatment regimen for isoniazid-resistant tuberculosis — MSF Tuberculosis (Médecins Sans Frontières)
- Treatment of rifampicin-susceptible and isoniazid-resistant tuberculosis — Introduction — MSF Tuberculosis (Médecins Sans Frontières)
- Surgery in Multidrug-Resistant and Rifampicin-Resistant Tuberculosis — MSF Tuberculosis (Médecins Sans Frontières)
- Treatment interruptions — MSF Tuberculosis (MSF)
- Treatment adaptation and change of treatment — MSF Tuberculosis (Médecins Sans Frontières)
- Adverse effects — MSF Tuberculosis (Médecins Sans Frontières)
- Patient Monitoring — Multidrug-Resistant and Rifampicin-Resistant Tuberculosis — MSF Tuberculosis (Médecins Sans Frontières)
- Guidance on evidence generation on new tuberculosis diagnostics (World Health Organization)
- Treatment regimens in operational research conditions — MSF Tuberculosis (Médecins Sans Frontières)
- Treatment of Multidrug-Resistant and Rifampicin-Resistant Tuberculosis: Introduction — MSF Tuberculosis (Médecins Sans Frontières)
- Patient monitoring — MSF Tuberculosis (Médecins Sans Frontières)
- Special situations in drug-susceptible tuberculosis treatment — MSF Tuberculosis (Médecins Sans Frontières)
- Standard code for treatment regimens — MSF Tuberculosis (Médecins Sans Frontières)
- Drug Susceptibility Pattern — Tuberculosis — MSF Tuberculosis (Médecins Sans Frontières)
- Bacteriological status — MSF Tuberculosis (Médecins Sans Frontières)
- High-risk groups — MSF Tuberculosis (Médecins Sans Frontières)
- MSF Tuberculosis: Chapter 6.1 Introduction — Screening for active tuberculosis — MSF Tuberculosis (Médecins Sans Frontières)
- Guidance for using diagnostic algorithm for pulmonary tuberculosis — MSF Tuberculosis (Médecins Sans Frontières)
- Other investigations — MSF Tuberculosis (Médecins Sans Frontières)
- Latent tuberculosis infection — MSF Tuberculosis (Médecins Sans Frontières)
- Active tuberculosis — MSF Tuberculosis (Médecins Sans Frontières)
- Summary of clinical presentations of tuberculosis — MSF Tuberculosis (Médecins Sans Frontières)
- Clinical presentation of tuberculosis in HIV-infected persons — MSF Tuberculosis (Médecins Sans Frontières)
- Disseminated or miliary tuberculosis — MSF Tuberculosis (Médecins Sans Frontières)
- Pulmonary tuberculosis — MSF Tuberculosis (Médecins Sans Frontières)
- Guidelines for the Structure of Public Health Entomology Laboratories (Pan American Health Organization)
- Interpretation of laboratory results for COVID-19 diagnosis (Pan American Health Organization)
- Guidance for Tuberculosis Prevention and Control in Indigenous Populations in the Region of the Americas (Pan American Health Organization)
- Operational handbook on tuberculosis: Module 4: treatment and care (World Health Organization)
- Operational handbook on tuberculosis. Module 3: Diagnosis (World Health Organization)
- Target Product Profile – Developing In Vitro Diagnostics for Low- and Middle-Income Settings (World Health Organization)
- Consolidated guidance on tuberculosis data generation and use: Module 4: Surveys of costs faced by households affected by tuberculosis (WHO)
- Consolidated guidance on tuberculosis data generation and use: Module 3 – National tuberculosis prevalence surveys (World Health Organization)
- Consolidated guidelines on tuberculosis: Module 4: Treatment and care (World Health Organization)
- Consolidated guidelines on tuberculosis. Module 3: Diagnosis (World Health Organization)
- Consolidated guidelines on tuberculosis. Module 6: tuberculosis and comorbidities, 2nd ed. (World Health Organization)
Also relevant to this standard: